XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $494,568 | -9.3% | 14,478 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $545,353 | +12.1% | 14,165 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $486,422 | -6.4% | 13,591 | +3.1% | 0.00% | -20.0% |
| Q4 2022 | $519,569 | +15.7% | 13,177 | +6.0% | 0.01% | 0.0% |
| Q3 2022 | $449,000 | +40.8% | 12,427 | +18.4% | 0.01% | +66.7% |
| Q2 2022 | $319,000 | -6.5% | 10,497 | -5.9% | 0.00% | 0.0% |
| Q1 2022 | $341,000 | +2.1% | 11,156 | +4.5% | 0.00% | 0.0% |
| Q4 2021 | $334,000 | – | 10,679 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
| GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
| DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
| Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
| Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
| Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
| BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |